Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,625.60
(
1.23%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
112.38
(
7.63%
)
Bitcoin
75,792.11
(
-0.72%
)
News Focus
News Focus
Post# of 517650
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Amatuer17

Send PM Follow Ignore
Followers 77
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Amatuer17

Re: F1ash post# 116196

Saturday, 08/19/2017 3:02:02 PM

Saturday, August 19, 2017 3:02:02 PM

Post# of 517650
Very logical and detailed explanation. Well inconvenient truths are ignored normally.

Some of the investors on this board know IPIX case. The P2B for their product beat current SOC so a P3 was natural - but as the 2 P3 trials would have costed $30 million - the company has shelved it indefinitely. This trial was much shorter period - literally single dose for efficacy and 2 follow ups.

My concern is - AVXL will do the same - delay ALZ trial as it is long term anf high cost - they will start Rett and P and delay Alz trial till they get a partner.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News